Latest Breaking News On - Campbell neurosciences - Page 3 : comparemela.com

Therapeutic Solutions International Announces Positive Early Clinical Data from Ongoing Suicidal Ideation Blood Biomarker Clinical Trial with Spinoff Campbell Neurosciences Three-Fold Increase in Inflammation Biomarker Observed in Patients with Suicidal Tendencies as Compared to Healthy Controls News provided by Share this article Share this article OCEANSIDE, Calif., Jan. 13, 2021 /PRNewswire/  Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today positive preliminary data from the Federally listed clinical trial Correlation of Campbell Score with Suicidal Ideation. 1 From a group of four healthy controls and four patients with suicidal ideations, the patients with suicidal ideations possessed approximately 3-fold higher levels of the inflammatory cytokine as compared to controls (24.2 ± 7.7 pg/ml vs 8.4 ±2.9 pg/ml). 

Timothy dixonKalina oconnorJames veltmeyerCampbell neurosciencesFamela ramosTherapeutic solutions international incCampbell teamBusiness development for therapeutic solutions internationalTherapeutic solutions internationalCampbell scoreSuicidal ideationChief medical officerTherapeutic solutionsKalinao connorChief executive officerVice president